Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Abemaciclib (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- Acronyms ABC-POP
- 07 Aug 2017 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.
- 07 Aug 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Mar 2018.
- 10 Jun 2017 Biomarkers information updated